KOREA UNITED PHARM. INC.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-06-18
Last Posted Date
2015-06-12
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
46
Registration Number
NCT02166398
Locations
🇰🇷

Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of

Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis

First Posted Date
2014-05-30
Last Posted Date
2014-05-30
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
242
Registration Number
NCT02151734

Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-04-26
Last Posted Date
2013-04-26
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
50
Registration Number
NCT01841086
© Copyright 2024. All Rights Reserved by MedPath